Clarification of methodology and further results from the pivotal phase 3 study of crisaborole for mild-moderate atopic dermatitis

A. S. Paller

doi:10.1111/bjd.16047

Clarification of methodology and further results from the pivotal phase 3 study of crisaborole for mild-moderate atopic dermatitis

A. S. Paller^*

^*Corresponding author for this work

Dermatology

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	663-664
Number of pages	2
Journal	British Journal of Dermatology
Volume	178
Issue number	3
DOIs	https://doi.org/10.1111/bjd.16047
State	Published - Mar 2018

ASJC Scopus subject areas

Dermatology

Access to Document

10.1111/bjd.16047

Cite this

@article{87e21638f0ed4bc8922f76ce57a609ac,

title = "Clarification of methodology and further results from the pivotal phase 3 study of crisaborole for mild-moderate atopic dermatitis",

author = "Paller, {A. S.}",

year = "2018",

month = mar,

doi = "10.1111/bjd.16047",

language = "English (US)",

volume = "178",

pages = "663--664",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Clarification of methodology and further results from the pivotal phase 3 study of crisaborole for mild-moderate atopic dermatitis

AU - Paller, A. S.

PY - 2018/3

Y1 - 2018/3

UR - http://www.scopus.com/inward/record.url?scp=85036496798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85036496798&partnerID=8YFLogxK

U2 - 10.1111/bjd.16047

DO - 10.1111/bjd.16047

M3 - Article

C2 - 29194568

AN - SCOPUS:85036496798

SN - 0007-0963

VL - 178

SP - 663

EP - 664

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 3

ER -

Clarification of methodology and further results from the pivotal phase 3 study of crisaborole for mild-moderate atopic dermatitis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this